pDONR223_AKR1B1_WT Citations (2)

Originally described in: High-throughput Phenotyping of Lung Cancer Somatic Mutations.
Berger AH, Brooks AN, Wu X, Shrestha Y, Chouinard C, Piccioni F, Bagul M, Kamburov A, Imielinski M, Hogstrom L, Zhu C, Yang X, Pantel S, Sakai R, Watson J, Kaplan N, Campbell JD, Singh S, Root DE, Narayan R, Natoli T, Lahr DL, Tirosh I, Tamayo P, Getz G, Wong B, Doench J, Subramanian A, Golub TR, Meyerson M, Boehm JS Cancer Cell. 2016 Aug 8;30(2):214-28. doi: 10.1016/j.ccell.2016.06.022. Epub 2016 Jul 28. PubMed Journal

---

Articles Citing pDONR223_AKR1B1_WT

Articles
Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study. Imran A, Shehzad MT, Shah SJA, Al Adhami T, Laws M, Rahman KM, Alharthy RD, Khan IA, Shafiq Z, Iqbal J. Sci Rep. 2022 Apr 6;12(1):5734. doi: 10.1038/s41598-022-09658-z. PubMed
Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway. Imran A, Shehzad MT, Shah SJA, Laws M, Al-Adhami T, Rahman KM, Khan IA, Shafiq Z, Iqbal J. ACS Omega. 2022 Jul 19;7(30):26425-26436. doi: 10.1021/acsomega.2c02326. eCollection 2022 Aug 2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.